# GPT-5.2 Review

**Role:** External referee review
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-25T13:22:51.839029
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 17716 in / 4230 out
**Response SHA256:** 0950f599ce2ee21b

---

## Referee Report: “Choking the Supply, Signing the Treaty: Mercury Regulation and Artisanal Gold Mining in Africa”

### Summary
The paper evaluates two major mercury-regulation interventions affecting Africa: (i) the 2011 EU Mercury Export Ban, and (ii) staggered Minamata Convention ratification. Using a 54-country panel (2000–2023) of mercury import values (HS 280540), the authors estimate a large negative effect of the EU ban for countries more exposed to EU mercury supply pre-2011 (a continuous “exposure” DiD), alongside strong evidence of trade diversion to non-EU hubs. For Minamata, TWFE suggests a positive association with mercury imports, but the Callaway–Sant’Anna (CS) estimator yields a statistically insignificant ATT.

The topic is important and under-studied; the paper is promising and unusually careful about modern staggered-adoption DiD issues. The main weaknesses are (i) the EU “exposure-share” design’s identification needs a much more explicit treatment of shift-share threats and alternative confounders, (ii) Minamata inference is underpowered and the “no detectable effect” message should be reframed accordingly, and (iii) several presentation/format issues (table/figure placement, labels, and some sections being too thin).

---

# 1) FORMAT CHECK

### Length
- **Meets**: The main text appears to be roughly **25–30 pages** in 12pt with 1.5 spacing (hard to pin down exactly from LaTeX source). Appendix adds additional pages.

### References / bibliography coverage
- **Mostly adequate**, especially on modern DiD (Callaway–Sant’Anna, Goodman-Bacon, Roth et al.). Policy-side mercury and ASGM citations are present.
- **However**, several foundational and closely related papers are missing (detailed below in Section 4), especially for:
  - shift-share/exposure designs and their diagnostics,
  - international environmental agreement (IEA) empirical evaluation,
  - recent TWFE alternatives beyond CS-DiD that could be used as robustness.

### Prose vs bullets
- **Pass**: Major sections are in paragraph form. Bullet points appear mainly in technical appendix, which is acceptable.

### Section depth
- **Introduction**: strong, multiple paragraphs (pass).
- **Institutional background**: good depth (pass).
- **Data**: adequate (pass).
- **Empirical strategy**: adequate but could use more discussion paragraphs on assumptions (borderline but pass).
- **Results**: several subsections have 2–3 paragraphs plus table/figure discussion (pass).
- **Discussion**: pass, but could better separate “interpretation” from “speculation”.

### Figures
- In LaTeX source, figures are included via `\includegraphics`. I cannot visually verify axes.
- **Do not flag as broken**, but I recommend a production check: ensure **axes labels, units, and sample definitions** are explicit in every figure.

### Tables
- **Pass**: tables contain real numbers, with SEs.
- **Format issue**: table labels are placed *after* the table environments (e.g., `\label{tab:eu_ban}` occurs after `\end{table}`), which can break cross-references in LaTeX. Move `\label{...}` inside the `table` environment right after `\caption{...}`.

---

# 2) STATISTICAL METHODOLOGY (CRITICAL)

### a) Standard errors for every coefficient
- **Pass overall** for displayed regression coefficients in key tables: SEs are in parentheses in Tables 1–3 and Appendix CS table.
- Some claims in text (e.g., “EU share fell by 25 percentage points… significant at 1%”) do not show the regression/table—either add a table/appendix entry or report the SE/CI explicitly.

### b) Significance testing
- **Pass**: stars, p-values, and joint tests are reported in places.

### c) 95% confidence intervals
- **Partially pass**: some key results report a 95% CI (e.g., EU ban main effect; CS ATT table implies CI but doesn’t show it).
- **Recommendation (important for top journals)**: report **95% CIs systematically** for headline estimates in each main table (EU ban baseline; Minamata TWFE; CS ATT; combined model).

### d) Sample sizes (N) reported
- **Pass**: `Num.Obs.` is included in main tables; cohort counts shown in appendix.
- For CS-DiD, also report **effective sample** used by estimator (countries x years after balancing/dropping missing) in a dedicated note—currently only briefly mentioned.

### e) DiD with staggered adoption
- **Pass**: you correctly flag TWFE bias and use **Callaway & Sant’Anna**. Good.
- Still, I would like to see at least one additional robustness estimator:
  - **Sun & Abraham (2021)** interaction-weighted event study, or
  - **Borusyak, Jaravel & Spiess (2021/2024)** imputation estimator,
  - **de Chaisemartin & D’Haultfoeuille** estimators.
  This is not required for validity, but would be standard for a top outlet.

### f) RDD
- Not applicable.

### Additional inference concerns
1. **Exposure-share (shift-share-like) inference**: Your EU design resembles shift-share; standard country-clustered SEs may not address exposure-induced correlation structures. The shock is common (EU ban) and the regressor is a pre-period share—this can induce non-standard dependence similar to Bartik designs. You cite Goldsmith-Pinkham et al. but do not implement their suggested diagnostics/inference.
   - At minimum: include **randomization/placebo inference** or **exposure-robust** standard errors, and show results robust to alternative pre-period share definitions.

2. **Few clusters**: 54 clusters is not tiny, but not huge. You mention wild bootstrap; however, I do not see wild-bootstrap p-values reported in the main tables. If you are relying on them, report them (or add an appendix table with analytic vs wild-bootstrap p-values).

**Bottom line**: No “fatal” inference omissions (you do have SEs), but for a top journal the EU “exposure” design needs more careful inference/diagnostics.

---

# 3) IDENTIFICATION STRATEGY

## EU Mercury Export Ban (continuous exposure DiD)
**Strengths**
- Clear shock timing (2011) and plausibly exogenous from African countries’ perspective.
- Event-study interaction with exposure share is a reasonable way to check differential pre-trends.
- You do multiple robustness checks (windows, IHS, exclude hubs, balanced reporters, leave-one-out).

**Key identification concerns (need more work)**
1. **Exposure share exogeneity**: The identifying assumption is not just “parallel trends”; it is that *pre-2011 EU dependence is as-good-as-random with respect to post-2011 changes in mercury demand/supply determinants*. In practice, EU dependence may correlate with:
   - colonial/trade ties and EU-oriented trade infrastructure,
   - governance/customs capacity (which also affects reported imports),
   - proximity to alternative hubs (UAE/Turkey),
   - gold-boom intensity and mining expansion.
   You partially address via FE and some controls, but the strongest threats are **time-varying confounders correlated with EUShare** (e.g., differential gold price pass-through, conflict, border enforcement).

2. **Measurement (value vs quantity)**: Using **import value** conflates quantity changes with price changes. A supply ban likely raises prices; you might see value fall less (or even rise) even if quantity falls. Conversely, rerouting might change unit values due to misreporting or insurance/freight differences.
   - If Comtrade/OEC provides quantities (kg), you should use **quantity** as the primary outcome (or at least show it as a robustness outcome).
   - Alternatively, compute **unit values** (value/quantity) to show whether effects are price-driven.

3. **Definition of treatment timing (Post ≥ 2012)**: Dropping 2011 is fine, but the event study shows a negative at k=0 (2011). That suggests partial effects already in 2011; you should formalize this:
   - show results if Post starts in 2011 (with partial-year caveats),
   - or implement a “donut” with 2010–2012 removed,
   - or define Post as 2011.5 in a monthly/quarterly setting if data exist (likely not).

4. **Trade diversion and “total effect”**: You show rerouting; but your EUShare×Post coefficient estimates *differential decline in total imports* for EU-dependent countries—not the decline in EU-origin mercury per se.
   - If rerouting fully offsets, then total imports might not drop; your finding suggests it did drop for high-EUShare countries at least in the short run. But then later you say total African imports did not fall proportionally.
   - You need to reconcile: (i) differential decline by exposure vs (ii) aggregate African trend. A helpful decomposition would be: for each importer, split outcome into EU-sourced and non-EU-sourced imports, and estimate effects separately.

**Suggested additions**
- A **first-stage** style figure: show EU-source imports collapse mechanically for high-EUShare countries, and non-EU imports rise (partial substitution). This would sharpen the mechanism.

## Minamata Convention (staggered adoption)
**Strengths**
- Correctly avoids relying on TWFE.
- Uses never-treated controls; also checks not-yet-treated.
- Transparent about small cohort sizes and power limitations.

**Concerns**
1. **Endogenous adoption timing remains central**: CS-DiD still relies on **conditional parallel trends**. With only log GDP per capita as a covariate, this seems too weak given your own narrative (“countries with rapid ASGM growth ratify earlier”). That is exactly a violation of parallel trends.
   - You should add covariates that proxy for ASGM growth and demand shocks: gold price exposure, mining rents, conflict indicators, governance capacity, pre-trends in mercury imports, etc.
   - Consider explicitly modeling selection with **event-study pre-trends by cohort** (even if imprecise) and show whether pre-trends are systematically positive for early ratifiers.

2. **Interpretation of null**: You correctly report MDE ~3.3 log points, but then language like “no detectable effect” should be prominent everywhere you claim “no effect.” The paper currently sometimes reads as a substantive null (“does not work”), which is too strong given power issues.

3. **NAP analysis**: The positive association between NAP submission and imports is interesting but likely even more selected (countries with serious problems both submit NAPs and import more). Treat this explicitly as descriptive unless you can strengthen identification (e.g., exploiting submission deadlines or donor-driven timing).

---

# 4) LITERATURE (Missing references + BibTeX)

Below are high-priority additions.

## (A) Shift-share / exposure designs and inference
You explicitly analogize to shift-share identification and cite Goldsmith-Pinkham et al. Add the core diagnostics and inference references:

```bibtex
@article{GoldsmithPinkhamSorkinSwift2020,
  author = {Goldsmith-Pinkham, Paul and Sorkin, Isaac and Swift, Henry},
  title = {Bartik Instruments: What, When, Why, and How},
  journal = {American Economic Review},
  year = {2020},
  volume = {110},
  number = {8},
  pages = {2586--2624}
}
```

```bibtex
@article{BorusyakHullJaravel2022,
  author = {Borusyak, Kirill and Hull, Peter and Jaravel, Xavier},
  title = {Quasi-Experimental Shift-Share Research Designs},
  journal = {Review of Economic Studies},
  year = {2022},
  volume = {89},
  number = {1},
  pages = {181--213}
}
```

These matter because your EUShare×Post is effectively an exposure design; top journals will ask about exposure-induced correlation and share exogeneity.

## (B) Alternative staggered DiD estimators (robustness)
You cite Sun & Abraham and Borusyak et al. in-text? You cite Sun (2021) and Borusyak (2024) in Empirical Strategy citations but do not include full references here. Make sure they’re in the bib and consider adding at least one estimator in robustness:

```bibtex
@article{SunAbraham2021,
  author = {Sun, Liyang and Abraham, Sarah},
  title = {Estimating Dynamic Treatment Effects in Event Studies with Heterogeneous Treatment Effects},
  journal = {Journal of Econometrics},
  year = {2021},
  volume = {225},
  number = {2},
  pages = {175--199}
}
```

```bibtex
@article{BorusyakJaravelSpiess2024,
  author = {Borusyak, Kirill and Jaravel, Xavier and Spiess, Jann},
  title = {Revisiting Event-Study Designs: Robust and Efficient Estimation},
  journal = {Review of Economic Studies},
  year = {2024},
  volume = {91},
  number = {6},
  pages = {3253--3295}
}
```

(Volume/pages should be checked against the final published version if different.)

## (C) International environmental agreement effectiveness / compliance
You cite some theoretical and empirical IEA work (Barrett; Aichele & Felbermayr; Aisbett). Consider anchoring more strongly with well-known surveys/empirics:

```bibtex
@article{Finus2008,
  author = {Finus, Michael},
  title = {Game Theoretic Research on the Design of International Environmental Agreements: Insights, Critical Remarks, and Future Challenges},
  journal = {International Review of Environmental and Resource Economics},
  year = {2008},
  volume = {2},
  number = {1},
  pages = {29--67}
}
```

If you want a more empirically oriented anchor, add work on treaty participation/compliance and environmental outcomes (exact best citations depend on your positioning; at minimum, one modern survey helps).

## (D) Mercury-specific policy / trade
Depending on what is already in `references.bib`, consider adding key UNEP/Minamata implementation and mercury trade measurement sources (many are reports, not journal articles). For top journals, it’s fine to cite reports, but make sure the academic backbone is strong.

---

# 5) WRITING QUALITY (CRITICAL)

### a) Prose vs bullets
- **Pass**.

### b) Narrative flow
- The introduction is strong: concrete stakes, clear interventions, preview of designs and results.
- The paper’s core “story” is compelling (hard supply regulation vs soft treaty commitment), but the results section sometimes blurs:
  - “EU ban reduced imports” vs “total imports didn’t decline proportionally” vs “rerouting.”
  A more explicit mapping from estimand → result → interpretation would improve clarity.

### c) Sentence quality
- Generally crisp and readable.
- Occasional over-strong causal language for Minamata (“shows no effect,” “treaty commitments show no detectable effect”) should be consistently hedged given power/endogeneity constraints.

### d) Accessibility
- Strong for non-specialists; good institutional context.
- The econometric intuition is mostly clear, but the EU exposure design’s assumptions should be explained more plainly (what must be true about EU dependence).

### e) Tables
- Tables are fairly self-contained, with notes and clustered SEs.
- Fix the `\label{}` placement.
- Consider adding a “Mean dep var” row for key regressions, and explicitly state transformation (log(1+x) vs IHS) in the row header.

---

# 6) CONSTRUCTIVE SUGGESTIONS (to strengthen contribution)

## A. Make the EU ban analysis closer to “unimpeachable”
1. **Quantity and unit value**:
   - Re-estimate key specs using **import quantities (kg)** and show **unit values** to separate price vs quantity effects.
2. **Outcome decomposition by origin**:
   - Estimate effects on **EU-origin imports** and **non-EU-origin imports** separately:
     - EU-origin should mechanically collapse more for high EUShare.
     - Non-EU-origin should rise if diversion occurs.
   This directly supports the mechanism and clarifies whether “total mercury available” fell.
3. **Exposure design diagnostics**:
   - Show that EUShare is not strongly predicted by pre-trends or key observables (balance table across EUShare quartiles; regression of EUShare on baseline covariates).
   - Consider **placebo shocks**: pretend the ban happened in 2007 or 2009 and show null “effects”.
4. **Inference robustness**:
   - Report **wild cluster bootstrap p-values** (country clusters) in main tables.
   - Consider exposure-robust approaches motivated by shift-share (even if only as robustness).

## B. Upgrade Minamata from “underpowered null” to more informative evidence
1. **Clarify estimand**: Ratification is a weak treatment. Consider focusing on:
   - **NAP submission**, **planetGOLD participation**, donor-funded program start dates, or other “implementation” events with clearer behavioral implications.
2. **Strengthen conditional parallel trends**:
   - Add covariates capturing mining demand and capacity (gold prices interacted with gold endowment; mining rents/GDP; conflict).
   - Consider controlling for **pre-treatment mercury import growth** or using matching/reweighting to align pre-trends.
3. **Heterogeneity / mechanisms**:
   - Estimate effects separately for “very high ASGM” countries where mercury is economically meaningful.
   - Consider a triple-difference: Minamata × ASGM intensity × post, within CS framework if possible (or report descriptive heterogeneity carefully).
4. **Power and interpretation**:
   - Elevate the MDE discussion into the main results and abstract/conclusion.
   - Reframe to: “we can rule out very large reductions in recorded imports, but moderate effects remain plausible.”

## C. Improve policy relevance
- The “waterbed” diversion finding is extremely policy relevant. You can quantify it:
  - How much of the lost EU-origin mercury is replaced by Turkey/UAE/India/China?
  - Provide a simple counterfactual: predicted imports absent ban vs with ban for high-exposure countries.
- Consider linking to **health outcomes** only cautiously; but you might add suggestive evidence using proxies (e.g., ASGM-related deforestation or nighttime lights near mining regions) if feasible.

---

# 7) OVERALL ASSESSMENT

### Key strengths
- Important, under-evaluated policy question with high external relevance.
- Clear separation of two interventions with different enforcement structures.
- Correct use of CS-DiD and explicit discussion of TWFE bias.
- Solid battery of robustness checks for EU ban.

### Critical weaknesses
- EU exposure-share design needs stronger defense against shift-share-style confounding and improved inference diagnostics.
- Mercury import **values** as the main outcome risks conflating quantity and price.
- Minamata analysis is informative but currently **too weakly identified and underpowered** to support strong conclusions about ineffectiveness; interpretation should be tempered and/or identification strengthened.

### Specific improvement priorities (highest ROI)
1. Add quantity/unit-value outcomes + origin decomposition (EU vs non-EU).
2. Add exposure-design diagnostics and placebo timing tests.
3. Strengthen Minamata identification (covariates, alternative treatments, clearer “detectable effect” framing).
4. Fix LaTeX labels and ensure all key claims are backed by displayed estimates.

**DECISION: MAJOR REVISION**